Hudson Bay Capital Management LP Akero Therapeutics, Inc. Transaction History
Hudson Bay Capital Management LP
- $24.1 Billion
- Q4 2024
A detailed history of Hudson Bay Capital Management LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 85,000 shares of AKRO stock, worth $3.58 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
85,000
Previous 155,000
45.16%
Holding current value
$3.58 Million
Previous $4.45 Million
46.83%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$311 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$289 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$254 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$235 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$220 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.96B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...